| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10046482 | HBV | ENSG00000010671.18 | protein_coding | BTK | Yes | No | 695 | Q06187 Q5JY90 |
| TVIS10057601 | HBV | ENSG00000010671.18 | protein_coding | BTK | Yes | No | 695 | Q06187 Q5JY90 |
| TVIS30021024 | HIV | ENSG00000010671.18 | protein_coding | BTK | Yes | No | 695 | Q06187 Q5JY90 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | BTK |
|---|---|
| DrugBank ID | DB11764 |
| Drug Name | Spebrutinib |
| Target ID | BE0001284 |
| UniProt ID | Q06187 |
| Regulation Type | inhibitor |
| PubMed IDs | 33689480; 34209188 |
| Citations | Zheng TJ, Lofurno ER, Melrose AR, Lakshmanan HHS, Pang J, Phillips KG, Fallon ME, Kohs TCL, Ngo ATP, Shatzel JJ, Hinds MT, McCarty OJT, Aslan JE: Assessment of the effects of Syk and BTK inhibitors on GPVI-mediated platelet signaling and function. Am J Physiol Cell Physiol. 2021 May 1;320(5):C902-C915. doi: 10.1152/ajpcell.00296.2020. Epub 2021 Mar 10.@@Kaliamurthi S, Selvaraj G, Selvaraj C, Singh SK, Wei DQ, Peslherbe GH: Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19. Int J Mol Sci. 2021 Jun 30;22(13). pii: ijms22137071. doi: 10.3390/ijms22137071. |
| Groups | Investigational |
| Direct Classification | Anilides |
| SMILES | COCCOC1=CC=C(NC2=NC=C(F)C(NC3=CC=CC(NC(=O)C=C)=C3)=N2)C=C1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL3301625 |
